From July 5, 2023 to July 11, 2023, the company has repurchased 1,121,900 shares, representing 0.25% for CNY 30.1 million. With this, the company has completed the repurchase of 1,121,900 shares, representing 0.25% for CNY 30.1 million under the buyback announced on July 5, 2023.
Guangzhou Wondfo Biotech Co.,Ltd
Equities
300482
CNE100002102
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.94 CNY | -0.55% | -3.15% | -4.08% |
05-06 | Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA | MT |
04-21 | Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.08% | 1.89B | |
-3.58% | 12.64B | |
-1.48% | 8.46B | |
+8.70% | 5.66B | |
+25.61% | 5.27B | |
-4.58% | 4.49B | |
-51.80% | 3.11B | |
+16.25% | 2.87B | |
+30.25% | 2.31B | |
+3.02% | 1.64B |
- Stock Market
- Equities
- 300482 Stock
- News Guangzhou Wondfo Biotech Co.,Ltd
- Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on July 5, 2023.